Market Place
Sourcing Support
Genespire raises 46.6M in a Series B to advance in-vivo therapy
24 Sep 2024 //
GLOBENEWSWIRE
Genespire appoints Karen Aiach-Pignet as Chief Executive Officer
12 Sep 2024 //
GLOBENEWSWIRE
Genespire Positive Preclinical Data At ASGCT Annual Meeting
09 May 2024 //
GLOBENEWSWIRE
Genespire appoints Dr. Sabah Sallah as Chief Medical Officer
06 Jul 2022 //
GLOBENEWSWIRE
Genespire appoints Philippe Mauberna as Chief Financial Officer
13 Jul 2021 //
GLOBENEWSWIRE
Italian gene therapy firm Genespire moving toward clinic with financing
18 May 2020 //
BIOWORLD
Genespire and SR-Tiget announce strategic alliance for the development
12 May 2020 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.